Maze Therapeutics Common Stock Volatility Indicators Average True Range
| MAZE Stock | 45.03 1.08 2.46% |
| Symbol |
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Maze Therapeutics Common volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Maze Therapeutics Technical Analysis Modules
Most technical analysis of Maze Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Maze from various momentum indicators to cycle indicators. When you analyze Maze charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Maze Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Maze Therapeutics Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Maze Therapeutics Common based on widely used predictive technical indicators. In general, we focus on analyzing Maze Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Maze Therapeutics's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Maze Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Maze Therapeutics, we also check how macroeconomic factors affect Maze Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 (projected) | PB Ratio | 69.45 | 3.55 | 4.08 | Capex To Depreciation | 0.11 | 0.35 | 0.4 |
Learn to be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Maze Therapeutics Common pair trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Maze Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maze Therapeutics will appreciate offsetting losses from the drop in the long position's value.Maze Therapeutics Pair Trading
Maze Therapeutics Common Pair Trading Analysis
The ability to find closely correlated positions to Maze Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Maze Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Maze Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Maze Therapeutics Common to buy it.
The correlation of Maze Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Maze Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Maze Therapeutics Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Maze Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maze Therapeutics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Will Pharmaceuticals sector continue expanding? Could Maze diversify its offerings? Factors like these will boost the valuation of Maze Therapeutics. Expected growth trajectory for Maze significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Maze Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Maze Therapeutics Common is measured differently than its book value, which is the value of Maze that is recorded on the company's balance sheet. Investors also form their own opinion of Maze Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Maze Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Maze Therapeutics' market value can be influenced by many factors that don't directly affect Maze Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Maze Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Maze Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Maze Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.